_id
6912ffcbccc777a4e85d7891
Ticker
IDRSF
Name
Idorsia Ltd
Exchange
PINK
Address
Hegenheimermattweg 91, Allschwil, Switzerland, 4123
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.idorsia.com
Description
Idorsia Ltd, a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland, the United States, Japan, Europe, China, and Canada. The company has a clinical development pipeline for various therapeutic areas, such as CNS, cardiovascular, immunological disorders, and orphan diseases. It offers QUVIVIQ (daridorexant) for the treatment of insomnia. The company's product pipeline includes Lucerastat, a glucosylceramide synthase inhibitor, which is in phase 3 clinical trial to treat fabry disease; Daridorexant, a dual orexin receptor antagonist, which is in phase 2 clinical trial for the treatment of pediatric insomnia; IDOR-1117-2520, a CCR6 receptor antagonist which is in phase 1 clinical program to treat immune-mediated disorders; ACT-777991, a CXCR3 antagonist, which is in preclinical trial to treat vitiligo; and ACT-1004-1239, an ACKR3 receptor antagonist which is preclinical trial for the treatment of progressive multiple sclerosis. It also develops ACT-1016-0707, a LPA 1 receptor antagonist to treat immune-mediated and fibrosis related disorders; IDOR-1141-8472, an orexin 2 receptor agonist to treat orexin-related CNS disorders; and IDOR-1126-6421 to treat organ injury. The company holds a license agreement with Neuro to develop and commercialize clazosentan; collaboration agreement with Janssen Biotech Inc. to jointly develop and commercialize aprocitentan and its derivative compounds or products; license agreement with Mochida Pharmaceutical for the supply, co-development, and comarketing of daridorexant; and optional license and/or research and development collaboration agreement with Neurocrine Biosciences, Inc, to to develop and commercialize ACT-709478, and/or to collaborate in a research program to discover, identify and develop novel calcium channel blocker compounds for follow-on compounds to ACT-709478. Idorsia Ltd was incorporated in 2017 and is headquartered in Allschwil, Switzerland.
Last Close
5.25
Volume
-
Current Price
4.75
Change
0
Last Updated
2026-01-04T15:00:28.913Z
Image
data:image/webp;base64,UklGRvAAAABXRUJQVlA4IOQAAACQBwCdASpAAEAAPrVUo06nJCejJBgKSPAWiUAamsRnvFIGYQcXWnWxtZbJbDKqYrhH0bsOyQG5nSD+70SLelvNDPiUQAAA/vwQSJlqBuLRNdDOfSU/dnkbv5jtSqPMfEqlGMdS3vQ5XLPVlo8p18QJ/8i1CRdlV09/Csjlo0+y5/+7F/Pg0sVD2SJ/W6r4i7jOtFFs191cHaxWMoJNsizIxU/b+3fkYNjon+F4cFrdNh/n0WR45vvHvJESVT3TTnKC6zSB5VPebvM6W0z+jPq9zkPZcQtjc8gvqlI11cXrDesxgAA=
Ipo Date
-
Market Cap
1290021120
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
52088184
Cost Of Revenue
12355375
Gross Profit
39732808
Operating Expenses
95902623
Operating Income
-56169814
Interest Expense
8531122
Pretax Income
-107343994
Net Income
-107569984
Eps
-0.5014917668997669
Dividends Per Share
-
Shares Outstanding
245718315
Income Tax Expense
225990
EBITDA
-93603802
Operating Margin
-107.83599981139676
Total Other Income Expense Net
-51174180
Cash
80114710
Short Term Investments
9281911
Receivables
44857759
Inventories
107974255
Total Current Assets
266007807
Property Plant Equipment
250385620
Total Assets
570713890
Payables
16622820
Short Term Debt
30317814
Long Term Debt
-
Total Liabilities
1996644249
Equity
-1425930358
Bs_currency_symbol
-
Depreciation
5209069
Change In Working Capital
27343534
Cash From Operations
-26024004
Capital Expenditures
200880
Cash From Investing
2778421
Cash From Financing
12862597
Net Change In Cash
-10717276
Cf_currency_symbol
-
PE
-
PB
-0.7145334933671424
ROE
7.543845559952656
ROA
-18.84832065327865
FCF
-26224884
Fcf Percent
-0.503470883146934
Piotroski FScore
1
Health Score
21
Deep Value Investing Score
1
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.8
Garp Investing Score
1
Growth Investing Score
1
Momentum Investing Score
5.5
Net Net Investing Score
0.5
Quality Investing Score
1
Value Investing Score
1.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
52088184
Quarters > 0 > income Statement > cost Of Revenue
12355375
Quarters > 0 > income Statement > gross Profit
39732808
Quarters > 0 > income Statement > operating Expenses
95902623
Quarters > 0 > income Statement > operating Income
-56169814
Quarters > 0 > income Statement > interest Expense
8531122
Quarters > 0 > income Statement > pretax Income
-107343994
Quarters > 0 > income Statement > net Income
-107569984
Quarters > 0 > income Statement > eps
-0.5014917668997669
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
214500000
Quarters > 0 > income Statement > income Tax Expense
225990
Quarters > 0 > income Statement > EBITDA
-93603802
Quarters > 0 > income Statement > operating Margin
-107.83599981139676
Quarters > 0 > income Statement > total Other Income Expense Net
-51174180
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
80114710
Quarters > 0 > balance Sheet > short Term Investments
9281911
Quarters > 0 > balance Sheet > receivables
44857759
Quarters > 0 > balance Sheet > inventories
107974255
Quarters > 0 > balance Sheet > total Current Assets
266007807
Quarters > 0 > balance Sheet > property Plant Equipment
250385620
Quarters > 0 > balance Sheet > total Assets
570713890
Quarters > 0 > balance Sheet > payables
16622820
Quarters > 0 > balance Sheet > short Term Debt
30317814
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
1996644249
Quarters > 0 > balance Sheet > equity
-1425930358
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-107569984
Quarters > 0 > cash Flow > depreciation
5209069
Quarters > 0 > cash Flow > change In Working Capital
27343534
Quarters > 0 > cash Flow > cash From Operations
-26024004
Quarters > 0 > cash Flow > capital Expenditures
200880
Quarters > 0 > cash Flow > cash From Investing
2778421
Quarters > 0 > cash Flow > cash From Financing
12862597
Quarters > 0 > cash Flow > net Change In Cash
-10717276
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.5014917668997669
Quarters > 0 > ratios > PB
-0.7145334933671424
Quarters > 0 > ratios > ROE
7.543845559952656
Quarters > 0 > ratios > ROA
-18.84832065327865
Quarters > 0 > ratios > FCF
-26224884
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-0.503470883146934
Quarters > 0 > health Score
21
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
72241000
Quarters > 1 > income Statement > cost Of Revenue
3388000
Quarters > 1 > income Statement > gross Profit
68853000
Quarters > 1 > income Statement > operating Expenses
71397000
Quarters > 1 > income Statement > operating Income
-2544000
Quarters > 1 > income Statement > interest Expense
8743000
Quarters > 1 > income Statement > pretax Income
-7674000
Quarters > 1 > income Statement > net Income
-11375000
Quarters > 1 > income Statement > eps
-0.0604089219330855
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
188300000
Quarters > 1 > income Statement > income Tax Expense
3700000
Quarters > 1 > income Statement > EBITDA
6006000
Quarters > 1 > income Statement > operating Margin
-3.5215459365180437
Quarters > 1 > income Statement > total Other Income Expense Net
-5130000
Quarters > 1 > income Statement > currency_symbol
CHF
Quarters > 1 > balance Sheet > cash
70966000
Quarters > 1 > balance Sheet > short Term Investments
11193000
Quarters > 1 > balance Sheet > receivables
69302000
Quarters > 1 > balance Sheet > inventories
66607000
Quarters > 1 > balance Sheet > total Current Assets
249045000
Quarters > 1 > balance Sheet > property Plant Equipment
205000000
Quarters > 1 > balance Sheet > total Assets
498011000
Quarters > 1 > balance Sheet > payables
24720000
Quarters > 1 > balance Sheet > short Term Debt
211438000
Quarters > 1 > balance Sheet > long Term Debt
981543000
Quarters > 1 > balance Sheet > total Liabilities
1639574000
Quarters > 1 > balance Sheet > equity
-1141563000
Quarters > 1 > balance Sheet > currency_symbol
CHF
Quarters > 1 > cash Flow > net Income
-11375000
Quarters > 1 > cash Flow > depreciation
4937000
Quarters > 1 > cash Flow > change In Working Capital
-34462000
Quarters > 1 > cash Flow > cash From Operations
-35262000
Quarters > 1 > cash Flow > capital Expenditures
9733000
Quarters > 1 > cash Flow > cash From Investing
-9733000
Quarters > 1 > cash Flow > cash From Financing
67039000
Quarters > 1 > cash Flow > net Change In Cash
21388000
Quarters > 1 > cash Flow > currency_symbol
CHF
Quarters > 1 > ratios > PE
-0.0604089219330855
Quarters > 1 > ratios > PB
-0.783509101118379
Quarters > 1 > ratios > ROE
0.9964408447015188
Quarters > 1 > ratios > ROA
-2.284086094483857
Quarters > 1 > ratios > FCF
-44995000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-0.6228457524120652
Quarters > 1 > health Score
15
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
58883000
Quarters > 2 > income Statement > cost Of Revenue
2441000
Quarters > 2 > income Statement > gross Profit
56442000
Quarters > 2 > income Statement > operating Expenses
-10223000
Quarters > 2 > income Statement > operating Income
66665000
Quarters > 2 > income Statement > interest Expense
7541000
Quarters > 2 > income Statement > pretax Income
63510000
Quarters > 2 > income Statement > net Income
63118000
Quarters > 2 > income Statement > eps
0.3351991502920871
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
188300000
Quarters > 2 > income Statement > income Tax Expense
393000
Quarters > 2 > income Statement > EBITDA
75378000
Quarters > 2 > income Statement > operating Margin
113.21603858499057
Quarters > 2 > income Statement > total Other Income Expense Net
-3155000
Quarters > 2 > income Statement > currency_symbol
CHF
Quarters > 2 > balance Sheet > cash
50678000
Quarters > 2 > balance Sheet > short Term Investments
14169000
Quarters > 2 > balance Sheet > receivables
33923000
Quarters > 2 > balance Sheet > inventories
62468000
Quarters > 2 > balance Sheet > total Current Assets
186429000
Quarters > 2 > balance Sheet > property Plant Equipment
211117000
Quarters > 2 > balance Sheet > total Assets
456170000
Quarters > 2 > balance Sheet > payables
25006000
Quarters > 2 > balance Sheet > short Term Debt
208307000
Quarters > 2 > balance Sheet > long Term Debt
931974000
Quarters > 2 > balance Sheet > total Liabilities
1588352000
Quarters > 2 > balance Sheet > equity
-1132182000
Quarters > 2 > balance Sheet > currency_symbol
CHF
Quarters > 2 > cash Flow > net Income
63118000
Quarters > 2 > cash Flow > depreciation
4327000
Quarters > 2 > cash Flow > change In Working Capital
-35552000
Quarters > 2 > cash Flow > cash From Operations
-60674000
Quarters > 2 > cash Flow > capital Expenditures
182000
Quarters > 2 > cash Flow > cash From Investing
6855000
Quarters > 2 > cash Flow > cash From Financing
-1652000
Quarters > 2 > cash Flow > net Change In Cash
-55698000
Quarters > 2 > cash Flow > currency_symbol
CHF
Quarters > 2 > ratios > PE
0.3351991502920871
Quarters > 2 > ratios > PB
-0.7900010775652677
Quarters > 2 > ratios > ROE
-5.574898735362336
Quarters > 2 > ratios > ROA
13.83650831926694
Quarters > 2 > ratios > FCF
-60856000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-1.0335071242973355
Quarters > 2 > health Score
39
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
59900000
Quarters > 3 > income Statement > cost Of Revenue
19894000
Quarters > 3 > income Statement > gross Profit
40006000
Quarters > 3 > income Statement > operating Expenses
118261000
Quarters > 3 > income Statement > operating Income
-78255000
Quarters > 3 > income Statement > interest Expense
5461000
Quarters > 3 > income Statement > pretax Income
-84141000
Quarters > 3 > income Statement > net Income
-84005000
Quarters > 3 > income Statement > eps
-0.44612320764737123
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
188300000
Quarters > 3 > income Statement > income Tax Expense
-136000
Quarters > 3 > income Statement > EBITDA
-74485000
Quarters > 3 > income Statement > operating Margin
-130.64273789649417
Quarters > 3 > income Statement > total Other Income Expense Net
-5886000
Quarters > 3 > income Statement > currency_symbol
CHF
Quarters > 3 > balance Sheet > cash
105376000
Quarters > 3 > balance Sheet > short Term Investments
17982000
Quarters > 3 > balance Sheet > receivables
65406000
Quarters > 3 > balance Sheet > inventories
62648000
Quarters > 3 > balance Sheet > total Current Assets
255479000
Quarters > 3 > balance Sheet > property Plant Equipment
216921000
Quarters > 3 > balance Sheet > total Assets
505895000
Quarters > 3 > balance Sheet > payables
35181000
Quarters > 3 > balance Sheet > short Term Debt
208586000
Quarters > 3 > balance Sheet > long Term Debt
931779000
Quarters > 3 > balance Sheet > total Liabilities
1718040000
Quarters > 3 > balance Sheet > equity
-1212145000
Quarters > 3 > balance Sheet > currency_symbol
CHF
Quarters > 3 > cash Flow > net Income
-84005000
Quarters > 3 > cash Flow > depreciation
4195000
Quarters > 3 > cash Flow > change In Working Capital
68688000
Quarters > 3 > cash Flow > cash From Operations
-11002000
Quarters > 3 > cash Flow > capital Expenditures
735000
Quarters > 3 > cash Flow > cash From Investing
-736000
Quarters > 3 > cash Flow > cash From Financing
26188000
Quarters > 3 > cash Flow > net Change In Cash
14741000
Quarters > 3 > cash Flow > currency_symbol
CHF
Quarters > 3 > ratios > PE
-0.44612320764737123
Quarters > 3 > ratios > PB
-0.7378861439844243
Quarters > 3 > ratios > ROE
6.930276493323818
Quarters > 3 > ratios > ROA
-16.605224404273613
Quarters > 3 > ratios > FCF
-11737000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.1959432387312187
Quarters > 3 > health Score
21
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
112508000
Annuals > 0 > income Statement > cost Of Revenue
35926000
Annuals > 0 > income Statement > gross Profit
76582000
Annuals > 0 > income Statement > operating Expenses
308596000
Annuals > 0 > income Statement > operating Income
-232014000
Annuals > 0 > income Statement > interest Expense
20124000
Annuals > 0 > income Statement > pretax Income
-263323000
Annuals > 0 > income Statement > net Income
-263757000
Annuals > 0 > income Statement > eps
-1.4456636721897318
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
182447000
Annuals > 0 > income Statement > income Tax Expense
434000
Annuals > 0 > income Statement > EBITDA
-225332000
Annuals > 0 > income Statement > operating Margin
-206.22000213318165
Annuals > 0 > income Statement > total Other Income Expense Net
-31309000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
105376000
Annuals > 0 > balance Sheet > short Term Investments
17982000
Annuals > 0 > balance Sheet > receivables
65406000
Annuals > 0 > balance Sheet > inventories
62648000
Annuals > 0 > balance Sheet > total Current Assets
255479000
Annuals > 0 > balance Sheet > property Plant Equipment
216921000
Annuals > 0 > balance Sheet > total Assets
505895000
Annuals > 0 > balance Sheet > payables
35181000
Annuals > 0 > balance Sheet > short Term Debt
208586000
Annuals > 0 > balance Sheet > long Term Debt
931779000
Annuals > 0 > balance Sheet > total Liabilities
1718040000
Annuals > 0 > balance Sheet > equity
-1212145000
Annuals > 0 > balance Sheet > currency_symbol
CHF
Annuals > 0 > cash Flow > net Income
-263757000
Annuals > 0 > cash Flow > depreciation
17867000
Annuals > 0 > cash Flow > change In Working Capital
-34778000
Annuals > 0 > cash Flow > cash From Operations
-370232000
Annuals > 0 > cash Flow > capital Expenditures
17990000
Annuals > 0 > cash Flow > cash From Investing
305057000
Annuals > 0 > cash Flow > cash From Financing
26108000
Annuals > 0 > cash Flow > net Change In Cash
-38676000
Annuals > 0 > cash Flow > currency_symbol
CHF
Annuals > 0 > ratios > PE
-1.4456636721897318
Annuals > 0 > ratios > PB
-0.7902080609168045
Annuals > 0 > ratios > ROE
21.759525469312667
Annuals > 0 > ratios > ROA
-52.13670821020172
Annuals > 0 > ratios > FCF
-388222000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-3.4506168450243537
Annuals > 0 > health Score
31
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
152386000
Annuals > 1 > income Statement > cost Of Revenue
7150000
Annuals > 1 > income Statement > gross Profit
145236000
Annuals > 1 > income Statement > operating Expenses
400381000
Annuals > 1 > income Statement > operating Income
-255145000
Annuals > 1 > income Statement > interest Expense
20668000
Annuals > 1 > income Statement > pretax Income
-294253000
Annuals > 1 > income Statement > net Income
-297921000
Annuals > 1 > income Statement > eps
-1.671394188962507
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
178247000
Annuals > 1 > income Statement > income Tax Expense
3668000
Annuals > 1 > income Statement > EBITDA
-254551000
Annuals > 1 > income Statement > operating Margin
-167.43336001994933
Annuals > 1 > income Statement > total Other Income Expense Net
-39108000
Annuals > 1 > income Statement > currency_symbol
CHF
Annuals > 1 > balance Sheet > cash
145052000
Annuals > 1 > balance Sheet > short Term Investments
12764000
Annuals > 1 > balance Sheet > receivables
57197000
Annuals > 1 > balance Sheet > inventories
59146000
Annuals > 1 > balance Sheet > total Current Assets
276284000
Annuals > 1 > balance Sheet > property Plant Equipment
209736000
Annuals > 1 > balance Sheet > total Assets
499996000
Annuals > 1 > balance Sheet > payables
19910000
Annuals > 1 > balance Sheet > short Term Debt
206122000
Annuals > 1 > balance Sheet > long Term Debt
931003000
Annuals > 1 > balance Sheet > total Liabilities
1468714000
Annuals > 1 > balance Sheet > equity
-968718000
Annuals > 1 > balance Sheet > currency_symbol
CHF
Annuals > 1 > cash Flow > net Income
-297921000
Annuals > 1 > cash Flow > depreciation
19034000
Annuals > 1 > cash Flow > change In Working Capital
-76267000
Annuals > 1 > cash Flow > cash From Operations
-629296000
Annuals > 1 > cash Flow > capital Expenditures
9398000
Annuals > 1 > cash Flow > cash From Investing
632614000
Annuals > 1 > cash Flow > cash From Financing
-197000
Annuals > 1 > cash Flow > net Change In Cash
-946000
Annuals > 1 > cash Flow > currency_symbol
CHF
Annuals > 1 > ratios > PE
-1.671394188962507
Annuals > 1 > ratios > PB
-0.9660156516137823
Annuals > 1 > ratios > ROE
30.754151362935346
Annuals > 1 > ratios > ROA
-59.58467667741342
Annuals > 1 > ratios > FCF
-638694000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-4.191290538500912
Annuals > 1 > health Score
31
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
97102000
Annuals > 2 > income Statement > cost Of Revenue
6266000
Annuals > 2 > income Statement > gross Profit
90836000
Annuals > 2 > income Statement > operating Expenses
893800000
Annuals > 2 > income Statement > operating Income
-802965000
Annuals > 2 > income Statement > interest Expense
17172000
Annuals > 2 > income Statement > pretax Income
-820089000
Annuals > 2 > income Statement > net Income
-827896000
Annuals > 2 > income Statement > eps
-4.665937757137866
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
177434000
Annuals > 2 > income Statement > income Tax Expense
7807000
Annuals > 2 > income Statement > EBITDA
-783088000
Annuals > 2 > income Statement > operating Margin
-826.9294144301869
Annuals > 2 > income Statement > total Other Income Expense Net
-17124000
Annuals > 2 > income Statement > currency_symbol
CHF
Annuals > 2 > balance Sheet > cash
145998000
Annuals > 2 > balance Sheet > short Term Investments
330326000
Annuals > 2 > balance Sheet > receivables
82571000
Annuals > 2 > balance Sheet > inventories
35840000
Annuals > 2 > balance Sheet > total Current Assets
596438000
Annuals > 2 > balance Sheet > property Plant Equipment
245468000
Annuals > 2 > balance Sheet > total Assets
904180000
Annuals > 2 > balance Sheet > payables
25435000
Annuals > 2 > balance Sheet > short Term Debt
8921000
Annuals > 2 > balance Sheet > long Term Debt
1129794000
Annuals > 2 > balance Sheet > total Liabilities
1565138000
Annuals > 2 > balance Sheet > equity
-660958000
Annuals > 2 > balance Sheet > currency_symbol
CHF
Annuals > 2 > cash Flow > net Income
-827896000
Annuals > 2 > cash Flow > depreciation
19829000
Annuals > 2 > cash Flow > change In Working Capital
-64697000
Annuals > 2 > cash Flow > cash From Operations
-859108000
Annuals > 2 > cash Flow > capital Expenditures
27058000
Annuals > 2 > cash Flow > cash From Investing
743901000
Annuals > 2 > cash Flow > cash From Financing
162310000
Annuals > 2 > cash Flow > net Change In Cash
44646000
Annuals > 2 > cash Flow > currency_symbol
CHF
Annuals > 2 > ratios > PE
-4.665937757137866
Annuals > 2 > ratios > PB
-1.4093611091778904
Annuals > 2 > ratios > ROE
125.25697548104418
Annuals > 2 > ratios > ROA
-91.56318432170586
Annuals > 2 > ratios > FCF
-886166000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-9.126135404008156
Annuals > 2 > health Score
31
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
35349000
Annuals > 3 > income Statement > cost Of Revenue
18033000
Annuals > 3 > income Statement > gross Profit
17316000
Annuals > 3 > income Statement > operating Expenses
648353000
Annuals > 3 > income Statement > operating Income
-613004000
Annuals > 3 > income Statement > interest Expense
27937000
Annuals > 3 > income Statement > pretax Income
-634805000
Annuals > 3 > income Statement > net Income
-634595000
Annuals > 3 > income Statement > eps
-3.766186062879494
Annuals > 3 > income Statement > dividends Per Share
594564000
Annuals > 3 > income Statement > shares Outstanding
168498048
Annuals > 3 > income Statement > income Tax Expense
-210000
Annuals > 3 > income Statement > EBITDA
-588835000
Annuals > 3 > income Statement > operating Margin
-1734.1480664233782
Annuals > 3 > income Statement > total Other Income Expense Net
-21801000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
101352000
Annuals > 3 > balance Sheet > short Term Investments
936773000
Annuals > 3 > balance Sheet > receivables
16697000
Annuals > 3 > balance Sheet > inventories
21717000
Annuals > 3 > balance Sheet > total Current Assets
1077462000
Annuals > 3 > balance Sheet > property Plant Equipment
223436000
Annuals > 3 > balance Sheet > total Assets
1482958000
Annuals > 3 > balance Sheet > payables
26860000
Annuals > 3 > balance Sheet > short Term Debt
10312000
Annuals > 3 > balance Sheet > long Term Debt
1092609000
Annuals > 3 > balance Sheet > total Liabilities
1378754000
Annuals > 3 > balance Sheet > equity
104204000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-634595000
Annuals > 3 > cash Flow > depreciation
18033000
Annuals > 3 > cash Flow > change In Working Capital
-841000
Annuals > 3 > cash Flow > cash From Operations
-589895000
Annuals > 3 > cash Flow > capital Expenditures
30931000
Annuals > 3 > cash Flow > cash From Investing
-53257000
Annuals > 3 > cash Flow > cash From Financing
604146000
Annuals > 3 > cash Flow > net Change In Cash
-39458000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-3.766186062879494
Annuals > 3 > ratios > PB
8.48925906874976
Annuals > 3 > ratios > ROE
-608.9929369314037
Annuals > 3 > ratios > ROA
-42.792513341578115
Annuals > 3 > ratios > FCF
-620826000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-17.562759908342528
Annuals > 3 > health Score
8
Valuation > metrics > PE
-0.5014917668997669
Valuation > metrics > PB
-0.7145334933671424
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
7.543845559952656
Profitability > metrics > ROA
-40.438656749649454
Profitability > metrics > Net Margin
-2.0651513594714688
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-6.58410628754342
Risk > final Score
4
Risk > verdict
High
Liquidity > metrics > Current Ratio
5.666898470097357
Liquidity > metrics > Quick Ratio
3.3666684604217316
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
70
Prev Valuations > 2
50
Prev Profitabilities > 0
2
Prev Profitabilities > 1
60
Prev Profitabilities > 2
14
Prev Risks > 0
29
Prev Risks > 1
65
Prev Risks > 2
-27
Prev Liquidities > 0
65
Prev Liquidities > 1
37
Prev Liquidities > 2
66
Updated At
2026-01-20T22:00:55.144Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-02-26
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-0.2
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-10-30
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.501
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-07-30
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
CHF
Earnings History > 2 > eps Actual
-0.0558
Earnings History > 2 > eps Estimate
-0.23
Earnings History > 2 > eps Difference
0.1742
Earnings History > 2 > surprise Percent
75.7391
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-19
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
CHF
Earnings History > 3 > eps Actual
0.2593
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-02-05
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
CHF
Earnings History > 4 > eps Actual
-0.5051
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-10-29
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
CHF
Earnings History > 5 > eps Actual
-0.5337
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-07-25
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
CHF
Earnings History > 6 > eps Actual
-0.6035
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-21
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
CHF
Earnings History > 7 > eps Actual
0.1464
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-03-20
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
CHF
Earnings History > 8 > eps Actual
-0.7363
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-09-30
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
CHF
Earnings History > 9 > eps Actual
1.0907
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-06-30
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
CHF
Earnings History > 10 > eps Actual
-1.1431
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-03-31
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
CHF
Earnings History > 11 > eps Actual
-1.2885
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-02-06
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
CHF
Earnings History > 12 > eps Actual
-1.09
Earnings History > 12 > eps Estimate
-1.34
Earnings History > 12 > eps Difference
0.25
Earnings History > 12 > surprise Percent
18.6567
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-10-24
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
CHF
Earnings History > 13 > eps Actual
-1.22
Earnings History > 13 > eps Estimate
-1.22
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
0
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-07-25
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
CHF
Earnings History > 14 > eps Actual
-1.24
Earnings History > 14 > eps Estimate
-1.24
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
0
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-04-25
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
CHF
Earnings History > 15 > eps Actual
-1.12
Earnings History > 15 > eps Estimate
-1.14
Earnings History > 15 > eps Difference
0.02
Earnings History > 15 > surprise Percent
1.7544
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-02-07
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
CHF
Earnings History > 16 > eps Actual
-1.32
Earnings History > 16 > eps Estimate
-1.3
Earnings History > 16 > eps Difference
-0.02
Earnings History > 16 > surprise Percent
-1.5385
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-10-25
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
CHF
Earnings History > 17 > eps Actual
-0.83
Earnings History > 17 > eps Estimate
-1.06
Earnings History > 17 > eps Difference
0.23
Earnings History > 17 > surprise Percent
21.6981
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-07-26
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
CHF
Earnings History > 18 > eps Actual
-0.83
Earnings History > 18 > eps Estimate
-0.91
Earnings History > 18 > eps Difference
0.08
Earnings History > 18 > surprise Percent
8.7912
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-04-21
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
CHF
Earnings History > 19 > eps Actual
-0.63
Earnings History > 19 > eps Estimate
-0.85
Earnings History > 19 > eps Difference
0.22
Earnings History > 19 > surprise Percent
25.8824
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2021-02-03
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
CHF
Earnings History > 20 > eps Actual
-0.85
Earnings History > 20 > eps Estimate
-0.9
Earnings History > 20 > eps Difference
0.05
Earnings History > 20 > surprise Percent
5.5556
Earnings History > 21 > period
2020-09-30
Earnings History > 21 > report Date
2020-10-26
Earnings History > 21 > date
2020-09-30
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
CHF
Earnings History > 21 > eps Actual
-0.83
Earnings History > 21 > eps Estimate
-0.85
Earnings History > 21 > eps Difference
0.02
Earnings History > 21 > surprise Percent
2.3529
Earnings History > 22 > period
2020-06-30
Earnings History > 22 > report Date
2020-07-22
Earnings History > 22 > date
2020-06-30
Earnings History > 22 > before After Market
AfterMarket
Earnings History > 22 > currency
CHF
Earnings History > 22 > eps Actual
-0.5
Earnings History > 22 > eps Estimate
-0.82
Earnings History > 22 > eps Difference
0.32
Earnings History > 22 > surprise Percent
39.0244
Earnings History > 23 > period
2020-03-31
Earnings History > 23 > report Date
2020-04-22
Earnings History > 23 > date
2020-03-31
Earnings History > 23 > before After Market
AfterMarket
Earnings History > 23 > currency
CHF
Earnings History > 23 > eps Actual
-0.9
Earnings History > 23 > eps Estimate
-0.86
Earnings History > 23 > eps Difference
-0.04
Earnings History > 23 > surprise Percent
-4.6512
Earnings History > 24 > period
2019-12-31
Earnings History > 24 > report Date
2020-02-05
Earnings History > 24 > date
2019-12-31
Earnings History > 24 > before After Market
AfterMarket
Earnings History > 24 > currency
CHF
Earnings History > 24 > eps Actual
-1.07
Earnings History > 24 > eps Estimate
-1
Earnings History > 24 > eps Difference
-0.07
Earnings History > 24 > surprise Percent
-7
Earnings History > 25 > period
2019-09-30
Earnings History > 25 > report Date
2019-10-21
Earnings History > 25 > date
2019-09-30
Earnings History > 25 > before After Market
AfterMarket
Earnings History > 25 > currency
CHF
Earnings History > 25 > eps Actual
-0.9
Earnings History > 25 > eps Estimate
-1.09
Earnings History > 25 > eps Difference
0.19
Earnings History > 25 > surprise Percent
17.4312
Earnings History > 26 > period
2019-06-30
Earnings History > 26 > report Date
2019-07-22
Earnings History > 26 > date
2019-06-30
Earnings History > 26 > before After Market
AfterMarket
Earnings History > 26 > currency
CHF
Earnings History > 26 > eps Actual
-0.95
Earnings History > 26 > eps Estimate
-0.99
Earnings History > 26 > eps Difference
0.04
Earnings History > 26 > surprise Percent
4.0404
Earnings History > 27 > period
2019-03-31
Earnings History > 27 > report Date
2019-04-17
Earnings History > 27 > date
2019-03-31
Earnings History > 27 > before After Market
AfterMarket
Earnings History > 27 > currency
CHF
Earnings History > 27 > eps Actual
-0.8
Earnings History > 27 > eps Estimate
-0.99
Earnings History > 27 > eps Difference
0.19
Earnings History > 27 > surprise Percent
19.1919
Earnings History > 28 > period
2018-12-31
Earnings History > 28 > report Date
2019-02-06
Earnings History > 28 > date
2018-12-31
Earnings History > 28 > before After Market
AfterMarket
Earnings History > 28 > currency
CHF
Earnings History > 28 > eps Actual
-0.8152
Earnings History > 28 > eps Estimate
-
Earnings History > 28 > eps Difference
0
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2018-09-30
Earnings History > 29 > report Date
2018-10-22
Earnings History > 29 > date
2018-09-30
Earnings History > 29 > before After Market
AfterMarket
Earnings History > 29 > currency
CHF
Earnings History > 29 > eps Actual
-0.91
Earnings History > 29 > eps Estimate
-0.79
Earnings History > 29 > eps Difference
-0.12
Earnings History > 29 > surprise Percent
-15.1899
Earnings History > 30 > period
2018-06-30
Earnings History > 30 > report Date
2018-07-23
Earnings History > 30 > date
2018-06-30
Earnings History > 30 > before After Market
AfterMarket
Earnings History > 30 > currency
CHF
Earnings History > 30 > eps Actual
-0.68
Earnings History > 30 > eps Estimate
-0.8
Earnings History > 30 > eps Difference
0.12
Earnings History > 30 > surprise Percent
15
Earnings History > 31 > period
2018-03-31
Earnings History > 31 > report Date
2018-04-18
Earnings History > 31 > date
2018-03-31
Earnings History > 31 > before After Market
AfterMarket
Earnings History > 31 > currency
CHF
Earnings History > 31 > eps Actual
-0.66
Earnings History > 31 > eps Estimate
-0.8
Earnings History > 31 > eps Difference
0.14
Earnings History > 31 > surprise Percent
17.5
Earnings History > 32 > period
2017-12-31
Earnings History > 32 > report Date
2018-02-05
Earnings History > 32 > date
2017-12-31
Earnings History > 32 > before After Market
AfterMarket
Earnings History > 32 > currency
CHF
Earnings History > 32 > eps Actual
0.49
Earnings History > 32 > eps Estimate
-0.8
Earnings History > 32 > eps Difference
1.29
Earnings History > 32 > surprise Percent
161.25
Earnings History > 33 > period
2017-09-30
Earnings History > 33 > report Date
2017-10-23
Earnings History > 33 > date
2017-09-30
Earnings History > 33 > before After Market
AfterMarket
Earnings History > 33 > currency
CHF
Earnings History > 33 > eps Actual
0.543
Earnings History > 33 > eps Estimate
-
Earnings History > 33 > eps Difference
0
Earnings History > 33 > surprise Percent
-
Earnings History > 34 > period
2017-06-30
Earnings History > 34 > report Date
2017-08-02
Earnings History > 34 > date
2017-06-30
Earnings History > 34 > before After Market
AfterMarket
Earnings History > 34 > currency
CHF
Earnings History > 34 > eps Actual
-0.11
Earnings History > 34 > eps Estimate
-0.8
Earnings History > 34 > eps Difference
0.69
Earnings History > 34 > surprise Percent
86.25
Earnings History > 35 > period
2017-03-31
Earnings History > 35 > report Date
2017-06-08
Earnings History > 35 > date
2017-03-31
Earnings History > 35 > before After Market
AfterMarket
Earnings History > 35 > currency
CHF
Earnings History > 35 > eps Actual
1.1525
Earnings History > 35 > eps Estimate
0
Earnings History > 35 > eps Difference
1.1525
Earnings History > 35 > surprise Percent
-
Earnings History > 36 > period
2016-12-31
Earnings History > 36 > report Date
2017-03-31
Earnings History > 36 > date
2016-12-31
Earnings History > 36 > before After Market
-
Earnings History > 36 > currency
CHF
Earnings History > 36 > eps Actual
-0.9612
Earnings History > 36 > eps Estimate
0
Earnings History > 36 > eps Difference
-0.9612
Earnings History > 36 > surprise Percent
-
Idorsia Ltd, a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland, the United States, Japan, Europe, China, and Canada. The company has a clinical development pipeline for various therapeutic areas, such as CNS, cardiovascular, immunological disorders, and orphan diseases. It offers QUVIVIQ (daridorexant) for the treatment of insomnia. The company's product pipeline includes Lucerastat, a glucosylceramide synthase inhibitor, which is in phase 3 clinical trial to treat fabry disease; Daridorexant, a dual orexin receptor antagonist, which is in phase 2 clinical trial for the treatment of pediatric insomnia; IDOR-1117-2520, a CCR6 receptor antagonist which is in phase 1 clinical program to treat immune-mediated disorders; ACT-777991, a CXCR3 antagonist, which is in preclinical trial to treat vitiligo; and ACT-1004-1239, an ACKR3 receptor antagonist which is preclinical trial for the treatment of progressive multiple sclerosis. It also develops ACT-1016-0707, a LPA 1 receptor antagonist to treat immune-mediated and fibrosis related disorders; IDOR-1141-8472, an orexin 2 receptor agonist to treat orexin-related CNS disorders; and IDOR-1126-6421 to treat organ injury. The company holds a license agreement with Neuro to develop and commercialize clazosentan; collaboration agreement with Janssen Biotech Inc. to jointly develop and commercialize aprocitentan and its derivative compounds or products; license agreement with Mochida Pharmaceutical for the supply, co-development, and comarketing of daridorexant; and optional license and/or research and development collaboration agreement with Neurocrine Biosciences, Inc, to to develop and commercialize ACT-709478, and/or to collaborate in a research program to discover, identify and develop novel calcium channel blocker compounds for follow-on compounds to ACT-709478. Idorsia Ltd was incorporated in 2017 and is headquartered in Allschwil, Switzerland.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AIdorsia Ltd (IDRSF) (Q4 2024) Earnings Call Highlights: Strategic Moves and Financial Resilience Yahoo Finance
Read more →Johnson & Johnson Q2 Earnings Preview: Scrutinizing Its Earnings Quality (NYSE:JNJ) - Seeking Alpha
7/11/2024
Johnson & Johnson Q2 Earnings Preview: Scrutinizing Its Earnings Quality (NYSE:JNJ) Seeking Alpha
Read more →Showing 2 of 5
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 0.00% of the total shares of Idorsia Ltd
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.2
Date
2025-09-30
EPS Actual
-0.501
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.